Celldex Q2 2024 Earnings Report
Key Takeaways
Celldex reported a net loss of $35.8 million, or ($0.54) per share, for the second quarter of 2024. The company's cash, cash equivalents and marketable securities totaled $802.3 million as of June 30, 2024, which is expected to fund operations through 2027. Total revenue was $2.5 million in the second quarter of 2024.
Cash, cash equivalents and marketable securities totaled $802.3 million as of June 30, 2024.
Total revenue was $2.5 million in the second quarter of 2024.
Research and development expenses were $39.7 million in the second quarter of 2024.
Net loss was $35.8 million, or ($0.54) per share, for the second quarter of 2024.
Celldex
Celldex
Forward Guidance
Celldex believes that the cash, cash equivalents and marketable securities at June 30, 2024 are sufficient to meet estimated working capital requirements and fund current planned operations through 2027.